Aktiesnakken — December 2020
-
DNB Markets @DNBMarkets
God morgen; Siden stengetid i Oslo på onsdag er S&P Futures +0.7%, Brent +0.7%, Equinor i USA -0.5%, Frontline +0.1%, Golden Ocean -0.3%, Nikkei i dag +0.6%, Hang Seng i dag -0.1%. Fokus i dag på BORR, CLOUD, HAFNI, SSO, Brexit, støttepakke, vaksineutrulling -
FINWIRE NEWS @Finwire
God morgon! De nordiska börserna öppnar idag efter julhelgen med tre handelsdagar kvar på året. Börserna i London och Toronto har helgstängt, som kompensation för att Annandag jul inföll på lördagen. Nelly Group handlas efter omvänd split 1:10. -
@Spinner0402: Ninja Trader findes stadig https://ninjatrader.com/ ellers kan du prøve med https://tradingview.com
-
Holger Zschaepitz
@Schuldensuehner
·
2h
Party like it's 1999! #Germany's Dax Index just hits intraday record high >13.8k. -
God morgen.
-
Tirsdagens danske avisuddrag med Egmont, Jysk og Brexithttps://www.proinvestor.com/investornyt/670700/tirsdagens-danske-avisuddrag-med-egmont-jysk-og-brexit
-
Fra Redeye.
Orphazyme: Our View to the Regulatory Update in NPCRedeye Research Note 2020/12/28
Redeye reiterates its probability rate for arimoclomol in NPC. While the extended NDA review, from previously March 17, 2021, updated to June 17, 2021, is initially disappointing, we also note that all outstanding information has now been submitted to the FDA. We consequently see a small risk for additional delays.
Background
The FDA has extended the NDA review period for arimoclomol in Niemann-Pick D -
(NPC) with a standard 90 days extension. The NDA remains under Priority Review, and the extension does not impact the eligibility for a potential Priority Review Voucher (PRV). The updated PDUFA date is set to June 17, 2021, extended from previously March 17, 2021.
-
Our View
We had looked forward to March 17, and believe we share the initial disappointment with the management team and investors on this delay. In the press release, we learn that Orphazyme has “responded to all FDA information requests and submitted all outstanding information regarding the arimoclomol NDA for NPC.” It also encompasses the crucial QTc clinical data. Thus, we see a small risk for additional delays. Based on the arguments below, we even believe that a potential decision by the -
sorry skulle under biotek
-
eter Schiff
@PeterSchiff
·
1 m
#Ripple just ripped below 20 cents. It traded above 60 cents earlier this month. Almost 70% of its market cap gets erased in less than a month based solely on the SEC's allegation that it's a security. What happens to the price of #Bitcoin
if the SEC alleges that it's a security? -
oe Weisenthal
@TheStalwart
·
7 min
Remarkable demonstration of Powell's credibility with the market that stocks are at all time highs, we just got another $1 trillion stimulus, there's a possibility of even larger checks, and yet 10-year yields are sub-0.94%. Traders do not see rate hikes anywhere on the horizon.https://twitter.com/TheStalwart/status/1343884861153693696 -
Er der virkelig nogen der vil betale penge for sådan noget bras? "På kanten af gigantisk rallysignal….. eller en korrektion ned på 5-10% https://ugebrev.dk/flashnews/investering/dax-future-europaeisk-aktiemarked-staar-paa-kanten-af-gigantisk-rallysignal/?mc_cid=1fd40446dc&mc_eid=398e30fe9c
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind